BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 2.42 EUR -1.63% Market Closed
Market Cap: 52.9m EUR

Intrinsic Value

The intrinsic value of one BNN stock under the Base Case scenario is 3.13 EUR. Compared to the current market price of 2.42 EUR, BRAIN Biotech AG is Undervalued by 23%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BNN Intrinsic Value
3.13 EUR
Undervaluation 23%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
BRAIN Biotech AG

What is Valuation History?
Ask AI Assistant
What other research platforms think about BNN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BNN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for BRAIN Biotech AG.

Explain Valuation
Compare BNN to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BNN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
BRAIN Biotech AG

Current Assets 30.2m
Other Current Assets 30.2m
Non-Current Assets 42.3m
Other Non-Current Assets 42.3m
Current Liabilities 12.6m
Other Current Liabilities 12.6m
Non-Current Liabilities 53.7m
Other Non-Current Liabilities 53.7m
Efficiency

Free Cash Flow Analysis
BRAIN Biotech AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
BRAIN Biotech AG

Revenue
53.6m EUR
Cost of Revenue
-23m EUR
Gross Profit
30.6m EUR
Operating Expenses
-39.3m EUR
Operating Income
-8.7m EUR
Other Expenses
-3m EUR
Net Income
-11.7m EUR
Fundamental Scores

BNN Profitability Score
Profitability Due Diligence

BRAIN Biotech AG's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Gross Margin is Increasing
Declining Net Margin
29/100
Profitability
Score

BRAIN Biotech AG's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

BNN Solvency Score
Solvency Due Diligence

BRAIN Biotech AG's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
Low Interest Coverage
36/100
Solvency
Score

BRAIN Biotech AG's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BNN Price Targets Summary
BRAIN Biotech AG

Wall Street analysts forecast BNN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BNN is 6.12 EUR with a low forecast of 4.55 EUR and a high forecast of 8.4 EUR.

Lowest
Price Target
4.55 EUR
88% Upside
Average
Price Target
6.12 EUR
153% Upside
Highest
Price Target
8.4 EUR
247% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

BRAIN Biotech AG
does not pay dividends
Shareholder Yield

Current shareholder yield for BNN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one BNN stock?

The intrinsic value of one BNN stock under the Base Case scenario is 3.13 EUR.

Is BNN stock undervalued or overvalued?

Compared to the current market price of 2.42 EUR, BRAIN Biotech AG is Undervalued by 23%.

Back to Top